Is ibogaine legal in Australia?
Ibogaine, a naturally occurring psychoactive substance derived from the root bark of the African shrub Tabernanthe iboga, has been gaining attention for its potential to treat addiction and facilitating profound…
Ibogaine Treatment in Australia: A Revolutionary Approach to Addiction Therapy
Ibogaine, a psychoactive indole alkaloid found in the West African shrub Tabernanthe iboga, has gained recognition for its potential in treating substance use disorders (SUDs). It has a historical background…
MDMA therapy for PTSD in Australia
MDMA-assisted therapy has shown significant promise in the treatment of various psychiatric disorders, including post-traumatic stress disorder (PTSD), depression, and anxiety. This article provides an overview of the best practices…
Penetration Test Action Plan
This is to meet Evidence item 9.2.3 in the NHS DSP toolkit. i.e. The person responsible for IT has reviewed the results of the latest penetration testing, with an action…
List of MDMA Clinical Trials
There has been a recent increase in interest in MDMA therapy as Lykos Therapeutics intends to launch MDMA as a licensed medicine towards the end of 2024. This marks a…
Understanding Health and Care Services
This document covers information needed by the NHS DSP Toolkit under Evidence item 7.1.1. Key attributes addressed include: i. What their key operational services are, ii. What technologies and services…
Pharmacy Training Needs Analysis (TNA) – Data Security and Protection
1. Introduction: Pharmacy Name: [Your Pharmacy Name] Date of Analysis: [Date] 2. Objectives: To assess the current knowledge and skills of pharmacy staff regarding data security and protection. To identify…
Pharmacy Privacy Notics for Data Security and Protection
(Name and address of pharmacy) Privacy Notice We process your personal data, which includes your name, contact details, prescription medicines and data from other pharmacy and health care services we…
MDMA Therapy Sydney
In 6 months (around June 2024) the FDA (US medicine regulator) will likely approve MDMA (ecstasy) as a licensed medicine in the US. This will present a pivotal moment for…
Pharmacy risk assessment for the sale of P medicines
If you are a distance-selling pharmacy attached to a private high street-based, pharmacy, the GPhC may want to inspect your premises to ensure that you are not offering face-to-face NHS…